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-Dystrobrevin is a dystrophin-related and -associated protein that is highly expressed in brain, kidney, and
liver. Recent studies with the kidneys of the mdx3Cv mouse, which lacks all dystrophin isoforms, suggest that
-dystrobrevin, and not the dystrophin isoforms, may be the key component in the assembly of complexes
similar to the muscle dystrophin-associated protein complexes (DPC) in nonmuscle tissues. To understand the
role of -dystrobrevin in the function of nonmuscle tissues, we generated -dystrobrevin-deficient (dtnb/)
mice by gene targeting. dtnb/ mice are healthy, fertile, and normal in appearance. No -dystrobrevin was
detected in these mice by Western blotting or immunocytochemistry. In addition, the levels of several -dys-
trobrevin-interacting proteins, namely Dp71 isoforms and the syntrophins, were greatly reduced from the basal
membranes of kidney tubules and liver sinusoids and on Western blots of crude kidney and liver microsomes
of -dystrobrevin-deficient mice. However, no abnormality was detected in the ultrastructure of membranes of
kidney and liver cells or in the renal function of these mice. -Dystrobrevin may therefore be an anchor or
scaffold for Dp71 and syntrophin isoforms, as well as other associating proteins at the basal membranes of
kidney and liver, but is not necessary for the normal function of these mice.
Dystrobrevins are a group of dystrophin-associated proteins
that have significant sequence homology with the cysteine-rich
C-terminal region of dystrophin, the product of the X-linked
Duchenne muscular dystrophy (DMD) gene. This region of
similarity can be divided into several protein-binding domains,
namely a ZZ domain, one or two syntrophin binding sites, and
two tandem -helical coiled coils. The syntrophin binding sites
mediate interaction with the syntrophins, a family of modular
adapter proteins, while the N-terminal -helical coiled coil
binds with the reciprocal region of dystrophin isoforms and
utrophin, the autosomal homologue of dystrophin (1, 7, 16,
20).
The dystrobrevin protein family comprises - and -dystro-
brevin. -Dystrobrevin is expressed predominantly in skeletal
muscle, heart, brain, and lung (4, 19). Differential splicing
of the -dystrobrevin message results in three successively C-
terminal-truncated isoforms in skeletal and cardiac muscle (4,
14). In skeletal muscle, -dystrobrevin is part of a multimo-
lecular dystrophin-associated protein complex (DPC) that con-
nects the actin cytoskeleton and the extracellular matrix
(ECM). This bridge is thought to be important for protecting
the muscle membrane from stresses incurred during con-
traction and relaxation. The DPC can be divided into three
subcomplexes, namely the membrane-spanning dystroglycan
complex, the muscle-specific sarcoglycan complex, and the cy-
toplasmic complex that comprises -dystrobrevin, syntrophin,
and dystrophin. In DMD muscle, the absence of dystrophin
results in muscle degeneration that is coupled with a dramatic
reduction of the DPC from the sarcolemma (1). In contrast,
targeted disruption of the -dystrobrevin gene in the mouse
leads to mild muscular dystrophy that does not interfere with
the assembly of the DPC at the sarcolemma. Since the cyto-
skeleton-ECM connection is not disrupted, it has been pro-
posed that the muscle degeneration observed in -dystro-
brevin-deficient mice (adbn/ mice) is due to deficiency in
intracellular signaling mediated by -dystrobrevin (9). At the
postsynaptic membrane of neuromuscular junctions (NMJs) of
skeletal muscle, -dystrobrevin associates with two complexes:
the DPC at the troughs and with utrophin in a complex not
unlike the DPC, but at the crests. The NMJs of abdn/ mice
mature abnormally, suggesting -dystrobrevin is required for
the maturation of the postsynaptic membrane (10). In brain,
-dystrobrevin-1 is present in the glia and microvasculature (2,
3). The effect of -dystrobrevin deficiency in this tissue is not
known.
-Dystrobrevin is a dystrophin-associated protein of un-
known function that is expressed in a wide variety of non-
muscle tissues, but is found most abundant in brain, kidney,
liver, and lung. In brain, -dystrobrevin associates with dystro-
phin in hippocampal and Purkinje neurons and is found highly
enriched in postsynaptic densities (2, 3). This finding is impor-
tant, since approximately a third of DMD patients have cog-
nitive impairment. In kidney, -dystrobrevin is part of several
different DPC-like complexes that are localized in a cell-type-
specific manner (12). In mdx3Cv mice that lack all known
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dystrophin isoforms, -dystrobrevin expression and localiza-
tion at the membrane in brain and kidney are not affected.
Thus, it has been speculated that this protein may be the key
regulator of DPC-like complex formation and maintenance in
nonmuscle tissues (2, 12). The -dystrobrevin gene (Dtnb) has
been mapped to the proximal region of mouse chromosome 12
and human chromosome 2p22–23 (11, 18). To date, this gene
is not associated with any known genetic disorder. To investi-
gate into the function of the protein, a mouse deficient for the
-dystrobrevin protein was generated by targeted disruption of
the Dtnb gene.
MATERIALS AND METHODS
Gene targeting construct. An 18-kb genomic fragment containing -dystro-
brevin coding exons 1, 2, and 3 was isolated from a mouse 129/SvJ genomic li-
brary in lambda FIX II (Stratagene) by using a 5-end mouse -dystrobrevin
cDNA clone. A 5.5-kb EcoRI fragment comprising exon 3 flanked by 3 and 2.5
kb of intronic sequence upstream and downstream, respectively, was subcloned
FIG. 1. (A) Targeted inactivation of the mouse -dystrobrevin gene. Restriction map of the wild-type allele of the Dtnb gene, the targeting
vector, and the predicted product of homologous recombination. An open box represents the targeted exon. The external probes used for the
Southern blot analyses are shown. B, BamHI; RI, EcoRI; RV, EcoRV; S, SacI. (B) Genotype analyses of offspring from heterozygote matings. The
top panel shows a Southern blot of EcoRV-digested genomic DNA from tail biopsies probed with a 1.2-kb EcoRV-EcoRI DNA fragment external
to the targeted site (probe A). The wild-type allele produces a 10.3-kb band, while the mutant allele produces a 12-kb band. The middle and
bottom panels show the products of PCR amplification of the mutant and wild-type alleles, respectively, of the same DNA samples.
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into pGEM7Zf() (Promega). A (TAG)3/IRES/lacZ/SV40pA/MC1neopA (15)
cassette was inserted into the EcoRV site of the exon. Two hundred micrograms
of the targeting construct was linearized with XhoI and purified with Geneclean
III (BIO 101) prior to electroporation.
Generation of dtnb/ mutant mice. One-hundred-fifty- and 50-g samples of
linearized targeting construct were introduced into 5  107 E14-TG2a.IV em-
bryonic stem (ES) cells by electroporation (800 V, 3 F in phosphate-buffered
saline). Recombinant ES cells were selected for G418 resistance. A total of 600
colonies were isolated and cultured in 96-well plates. The correct targeting events
were determined by Southern blot analysis of BamHI- and EcoRV-digested ES
cell DNA with probes 5 and 3 to the targeted site (Fig. 1A). Three clones
containing the correct targeting event were injected into C57BL/6 blastocysts,
which were then transferred into pseudopregnant females. Thirteen chimeras
were produced, of which 12 were male, and all were 80 to 90% chimeric by coat
color. Four male chimeras from the three clones were bred with C57BL/6
females, and germ-line transmission was determined by Southern blot analysis of
DNA from tail biopsies of agouti coat-colored offspring. dtnb/ mice derived
from the test crosses were mated to produce dtnb/ offspring at a ratio of 1:4.
All mice used in subsequent analyses were over 8 weeks old.
Genotyping. Mice were genotyped by Southern blot or PCR analysis of DNA
from tail biopsies. For Southern blot analysis, DNA from tail biopsies was
digested with EcoRV with or without a second digestion with BamHI, resolved
on a 1% agarose gel, and transferred onto Hybond N membrane (Amersham
Pharmacia). Blots were probed with either a 1.2-kb EcoRV-EcoRI 5 probe
(probe A) for EcoRV-digested DNA or a 0.7-kb SacI-BamHI 3 probe (probe B)
for EcoRV-BamHI-digested DNA. PCR analyses of DNA from tail biopsies
were performed as follows. The mutant allele was amplified with the IRES T3
primer (5GATTCGCAGCGCATCGCCTTC) and the 487R primer (5TGTC
GTAGGCGGCGACCAT), while the wild-type allele was amplified with the
5Ex3 primer (5TGTCCAGTTGTGAGGTGACAC) and the 487R primer.
Both PCRs were performed under the following cycling conditions: 1 cycle of
94°C for 4 min, 58°C for 2 min, and 72°C for 6 min, followed by 30 cycles of 94°C
for 50 s, 58°C for 50 s, and 72°C for 50 s, and then 1 cycle of 94°C for 2 min, 58°C
for 2 min, and 72°C for 6 min.
Antibodies. All antibodies mentioned in this paper have been described pre-
viously: CT-FP (anti--dystrobrevin and anti--dystrobrevin-1 and -2) and
1CT-FP (anti--dystrobrevin-1) (3); 521 (anti--dystrobrevin), URD40
(antiutrophin), 2166, which was raised against the last 17 amino acids of mouse
dystrophin (antidystrophin, Dp71), and 2401, which was raised against the alter-
natively spliced C terminus of dystrophin (anti-Dp71	C) (2); and isoform-spe-
cific antisyntrophin antibodies 2688 (anti--syntrophin), 2689 (anti-1-syntro-
phin), and 2045 (anti-2-syntrophin) (12). Antiactin antibody was purchased
from Sigma-Aldrich (catalog no. A2066).
Western blot analysis. Protein extracts were prepared essentially as described
in reference 12. Briefly, fresh frozen tissues were homogenized in treatment
buffer (75 mM Tris-HCl [pH 6.8], 4 M urea, 3.8% sodium dodecyl sulfate (SDS),
20% [vol/vol] glycerol, 5% [vol/vol] 2-mercaptoethanol). Twenty micrograms of
proteins from each tissue were separated on SDS-polyacrylamide gel electro-
phoresis (PAGE) gels (8% polyacrylamide) and transferred onto nitrocellulose
membranes (Schleicher and Schuell) in transfer buffer (20% ethanol, 0.1% SDS,
192 mM glycine, 25 mM Tris-HCl [pH 8.5]). Membranes were blocked in 5%
milk powder in Tris-buffered saline–Tween 20 (TBST; 150 mM NaCl, 50 mM
Tris-HCl [pH 7.5], 0.1% Tween 20) for an hour. Blots were incubated for an hour
at room temperature with antibodies in 5% milk–TBST solution at the following
concentrations: CT-FP, 1:1,000; 1CT-FP, 1:3,000; URD40, 1:250; 2166, 1:500;
or 2401, 1:50. Blots were subsequently washed twice in TBST and twice in 5%
milk–TBST for 5 min each. Horseradish peroxidase-conjugated donkey anti-
rabbit antibodies (Jackson ImmunoResearch) were applied at 1:3,000 in 5%
milk–TBST for 1 h at room temperature after which the membranes were
washed four times in TBST. Bound antibodies were detected with a BM chemi-
luminescence detection kit (Roche).
Microsome preparation and analysis. Crude microsomes from dtnb/ and
dtnb/ kidneys and liver were prepared in the following manner. Fresh frozen
kidneys and liver were homogenized in 2 or 4 ml of ice-cold microsome buffer
containing 300 mM sucrose, 10 mM PIPES [piperazine-N, N-bis(2-ethanesul-
fonic acid)] (pH 6.8), 10 mM NaCl, 3 mM MgCl2, 1 mM EGTA, and protease
inhibitors (Complete; Roche). Homogenates were centrifuged at 700  g for 10
min at 4°C to pellet the nuclear fraction. The postnuclear supernatant was passed
through a sieve with pore size of 40 m (Falcon) and then centrifuged at
141,000  g at 4°C for 45 min with an SW41 Ti rotor (Beckman) to pellet
insoluble material. The supernatant was carefully removed, and the pellet was
homogenized in half of the original volume of ice-cold microsome buffer. Thirty
micrograms of microsomes was separated on SDS-PAGE gels (8% polyacryl-
amide) and processed for Western blot analysis with the CT-FP (1:1,000),
1CT-FP (1:3,000), URD40 (1:250), 2166 (1:500), 2401 (1:50), 2689 (1:250), and
antiactin (1:500) antibodies.
Immunofluorescence analysis. Ten-micrometer cryosections of kidneys and
liver were processed for immunofluorescence labeling as previously described
(12). Slides were incubated for 1 h at room temperature in primary antibodies
diluted in TBS (150 mM NaCl, 50 mM Tris-HCl [pH 7.5]) at the following
dilutions: 521, 1:200; 1CT-FP, 1:250; URD40, 1:250; 2401, 1:20; 2688, 1:50;
2689, 1:200; and 2045, 1:100. This was followed by incubation with rhodamine
red-X-conjugated donkey anti-rabbit antibodies (Jackson ImmunoResearch) at a
dilution of 1:100. Washed slides were mounted in Vectashield (Vector Labora-
tories), visualized with a Leica DMRE fluorescence microscope, and photo-
graphed with a Leica DMLD camera. For direct comparison of fluorescence
intensity, dtnb/ and dtnb/ tissues were photographed under identical set-
tings.
Urine analysis. Spot urine samples were obtained from mice 
6 months old
and assayed for creatinine, protein, calcium, and glucose levels on the day of
sampling. Urine creatinine was measured by using the alkaline picrate colori-
metric assay (Sigma-Aldrich). Total protein was measured by using the Bio-Rad
protein assay kit. Calcium levels were measured with the calcium-cresolphthalein
colorimetric assay (Sigma-Aldrich). Glucose was measured with the Infinity
glucose reagent (Sigma-Aldrich). All assays were performed according to the
manufacturer’s instructions. Urine samples were diluted 1:20 in deionized water
for creatinine and protein assays. Ratios of urine protein to creatinine, calcium
to creatinine, and glucose to creatinine were used as indices of proteinuria,
calciuria, and glucouria, respectively. The data are presented as means  stan-
dard errors. The statistical significance of the difference between mean values of
test and control groups was assessed by using the two-tailed Student’s t test.
Differences between mean values of mutant and control groups were considered
significant when the P value was 0.05.
RESULTS
Generation of dtnb/ mice and their phenotype. The -dys-
trobrevin gene spans over 130 kb and comprises at least 21
FIG. 2. Western blot analyses. Twenty micrograms (each) of total
protein extracts from brain, kidneys, and liver of dtnb/, dtnb/, and
dtnb/ littermates was probed with CT-FP (A), 1CT-FP (B),
URD40 (C), 2166 (D), and 2401 (E) antibodies. The proteins that are
recognized by these antibodies are shown to the right of the panels,
while the positions of protein standards are shown to the left in kilo-
daltons. db, dystrobrevin.
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exons, 5 of which are alternatively spliced in a tissue-specific
manner. Furthermore, there is evidence that this gene is reg-
ulated by at least two promoters (11). To ensure that all known
-dystrobrevin isoforms were disrupted, a (TAG)3/IRES/lacZ/
SV40pA/MC1neopA (15) cassette was inserted into exon 3,
which encodes part of the EF hand region that is present in all
known -dystrobrevin isoforms, to disrupt the reading frame
(Fig. 1A). This cassette contains stop codons in three open
reading frames at the 5 end of the internal ribosome entry site
(IRES) cassette to ensure that only a truncated form of the
-dystrobrevin protein is produced. The mutation was intro-
duced into ES cells by homologous recombination. Matings
between chimeric male mice and C57BL/6 female mice pro-
duced heterozygous offspring, indicating that the mutation was
transmitted through the germ line. Matings between heterozy-
gous mice produced offspring that were wild type and heterozy-
gous or homozygous for the mutation (Fig. 1B) at a ratio of
1:2:1.
Mice that are heterozygous (dtnb/) and homozygous
(dtnb/) for the mutant gene were viable, fertile, and indis-
tinguishable from their wild-type littermates. Histological ex-
amination of various tissues by hematoxylin and eosin staining
revealed no gross morphological abnormality (data not shown).
No -dystrobrevin was detected in the dtnb/ tissues either
on Western blots or by immunofluorescence examination (Fig.
2A, 3A, and 4A). Levels of -dystrobrevin in dtnb/ tissues
were reduced by up to half of the levels seen in dtnb/ tissues,
showing that in normal tissues, both copies of the gene are
active (Fig. 2A). To analyze the effect of -dystrobrevin loss on
the levels of other dystrophin-related proteins and isoforms,
Western blot analyses were performed with the same samples
with antibodies against -dystrobrevin-1, utrophin, and two
C-terminal splice forms of dystrophin and Dp71. No difference
could be detected in the levels of any of the proteins in brain
or liver (Fig. 2B to E). However, in dtnb/ kidney, there
appeared to be a moderate increase in -dystrobrevin-1
(Fig. 2B), while levels of Dp71 and Dp71	C were noticeably
reduced (Fig. 2D and E).
-Dystrobrevin loss affects the localization of Dp71C and
syntrophins at the basal region of cortical renal tubules and
liver sinusoids. To analyze the effect of -dystrobrevin defi-
ciency on the distribution of dystrophin-related and associated
proteins, we performed immunofluorescence analyses of dtnb/
and dtnb/ kidneys by using isoform-specific antibodies. In nor-
mal kidney, -dystrobrevin is present in glomeruli, Bowman’s
capsules, and the basolateral membranes of cortical renal tubules
and collecting ducts, whereas -dystrobrevin-1 is restricted to the
glomeruli, blood vessels, and a subset of cortical renal tubules
(Fig. 3A and B) (12). As expected no -dystrobrevin was detected
in dtnb/ kidneys (Fig. 3A). Surprisingly, in light of the increase
in the overall level of -dystrobrevin-1 in dtnb/ kidney, no
difference was detected in the localization of -dystrobrevin-1 in
FIG. 3. Immunofluorescence examination of dystrophin-related
and -associated proteins in wild-type control (A to I) and dtnb/ (A
to I) kidneys. Kidney cryosections were probed with 521 (anti--
dystrobrevin; A and A), 1CT-FP (anti--dystrobrevin-1; B and B),
URD40 (anti-utrophin; C and C), 2401 (anti-Dp71	C; D and D),
2688 (anti--syntrophin; E and E), 2045 (anti-2-syntrophin; F, F,
G, and G), and 2689 (anti-1-syntrophin; H, H, and I, I). dtnb/
kidneys were prepared and photographed under identical conditions to
control kidneys for comparison of fluorescence intensity. Arrows indi-
cate the basal membranes of cortical renal tubules, and arrowheads
indicate blood vessels. db, dystrobrevin, utro, utrophin, syn, syntro-
phin. Bar, 100 m.
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dtnb/ kidney by immunofluorescence. Nor was there any obvi-
ous increase in overall staining intensity with the 1CT-FP anti-
body (Fig. 3B). Thus, the moderate increase in -dystrobrevin-1
on Western blots of dtnb/ kidney is not due to compensation
for the absence of -dystrobrevin in renal tubules and collecting
ducts.
Previously, we showed that -dystrobrevin colocalizes and
coimmunoprecipitates with utrophin, Dp71	C, and the syntro-
phins in normal kidney (12). Here, we found no difference in
utrophin staining in control and dtnb/ kidneys (Fig. 3C and
C). In contrast, Dp71	C, which is present in the basal regions
of normal cortical renal tubules (Fig. 3D), was markedly re-
duced or undetectable in corresponding regions of dtnb/
kidneys. Similar results were observed with -syntrophin (Fig.
3E and E) and 2-syntrophin (Fig. 3F and F) in this region.
In addition, 2-syntrophin staining was lost from collecting
ducts (Fig. 3G and G), but not from glomeruli of dtnb/
kidneys (Fig. 3F and F). -Syntrophin staining in collecting
ducts was unchanged (data not shown). The persistence of
2-syntrophin at the glomerulus could be due to the presence
of -dystrobrevin-1 or utrophin, while the retention of -syn-
trophin in collecting ducts may be due to utrophin or another
membrane-associated protein. In normal kidney, 1-syntro-
phin is found in blood vessels, a subset of cortical renal tubules,
and corticomedullary collecting tubules (Fig. 3H and I). In the
dtnb/ kidneys, there was a marked decrease in 1-syntrophin
staining from the latter two structures, but levels were unal-
tered in blood vessels (Fig. 3H and I).
To determine if -dystrobrevin loss had a similar effect on its
known ligands in liver, a similar study was conducted with liver
cryosections of control and dtnb/ mice. In normal liver,
-dystrobrevin, Dp71	C, and 1-syntrophin are localized at
the sinusoids and/or at the sinusoidal face of hepatocytes, but
not in capillaries or large blood vessels (Fig. 4A, D, and E).
Conversely, -dystrobrevin-1 is found in capillaries and large
blood vessels, but not in sinusoids (Fig. 4B), while utrophin is
present in both sinusoids and larger blood vessels (Fig. 4C). As
expected, -dystrobrevin was undetectable in dtnb/ liver
(Fig. 4A). Again, distribution of -dystrobrevin-1 and utro-
phin was unaltered in dtnb/ liver (Fig. 4B and C). How-
ever, no Dp71	C staining was detectable at the sinusoids,
while the intensity of 1-syntrophin staining was reduced to a
third of that seen in control liver (Fig. 4D and E).
-Dystrobrevin facilitates membrane association of Dp71
isoforms in kidney and liver. To confirm our immunofluores-
cence findings, we prepared microsomes from kidney and liver
of control and dtnb/ mice and analyzed their protein content
by Western blotting. As predicted, -dystrobrevin was detected
at high levels in microsomes prepared from kidney and liver of
control mice, but not dtnb/ mice (Fig. 5A). In agreement
with the immunofluorescence data, no obvious difference was
seen in the levels of -dystrobrevin-1 or utrophin between
control and dtnb/ kidney microsomes or the levels of utro-
phin between control and dtnb/ liver microsomes (Fig. 5B
and C). In contrast, there was at least a twofold decrease in the
levels of Dp71	C and 1-syntrophin in dtnb/ kidney micro-
somes and in the levels of the Dp71 isoforms and 1-syntro-
phin in dtnb/ liver microsomes compared with the levels of
these proteins in corresponding control tissues (Fig. 5D to F).
These findings suggest that the loss of immunofluorescence
staining observed in dtnb/ kidney and liver is connected with
their disassociation from the membrane. Levels of actin, a
protein not known to interact with -dystrobrevin, were not
noticeably different in microsomes of dtnb/ and wild-type
tissues (Fig. 5G).
Urine and ultrastructural analyses. To identify possible
changes in renal function resulting from this mutation, spot
urine samples were obtained from dtnb/ mice and their
heterozygous and wild-type littermates and analyzed for ab-
normal levels of proteinuria, calciuria, and glucouria. The re-
sults of our findings are tabulated in Table 1. The differences
in protein/creatinine and calcium/creatinine ratios from all
groups were not statistically significant. The glucose/creatinine
ratios in samples from male and female mice of the dtnb/
and dtnb/ groups were not significantly different. The glu-
cose/creatine value of the samples from female dtnb/ mice
was significantly different from that of wild-type females at P
0.05. This could be due to the small sample size, since the
differences between glucose/creatinine ratios of wild-type and
FIG. 4. Immunofluorescence analyses of wild-type control (A to E)
and dtnb/ (A to E) liver. Liver cryosections were probed with 521
(anti--dystrobrevin; A and A), 1CT-FP (anti--dystrobrevin-1; B
and B), URD40 (anti-utrophin; C and C), 2401 (anti-Dp71	C; D and
D), and 2689 (anti-1-syntrophin; E and E) antibodies. dtnb/ livers
were prepared and photographed under identical conditions as control
liver for comparison of fluorescence intensity. Arrows indicate sinu-
soids. db, dystrobrevin; utro, utrophin; syn, syntrophin. Bar, 100 m.
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dtnb/ male mice and the differences between the pooled
data from male and female mice were found to be not signif-
icant (P 
 0.7 for pooled data).
To determine if the loss of -dystrobrevin led to ultrastruc-
tural changes in kidney and liver cells, dtnb/ and control
kidneys and liver were examined by electron microscopy. We
could find no obvious difference in the ultrastructure of the
basolateral membranes of tubular epithelia and podocyte foot
processes in kidney or in the ultrastructural features of the
sinusoids or the sinusoidal face of hepatocytes in liver of
dtnb/ mice (data not shown).
DISCUSSION
We have generated mice with a targeted mutation in exon 3
of the -dystrobrevin gene. -Dystrobrevin was undetectable
in tissues from mice that were homozygous for the mutation by
Western blotting and immunohistochemistry, confirming that
this mutation abolishes all known -dystrobrevin isoforms. De-
spite the expression of -dystrobrevin in many tissues, dtnb/
mice are viable, fertile, and show no obvious histological ab-
normality. Limited investigation of urine samples has so far
revealed no functional significance of this mutation to the
kidney. Normal expression of -dystrobrevin-1 in dtnb/ kid-
ney and liver suggests that -dystrobrevin-1 is not compensat-
ing for the absence of -dystrobrevin in these tissues.
One similarity between the loss of -dystrobrevin in kidney
and liver and the loss of dystrophin in skeletal muscle is the
effect of these molecules on the localization of their ligands. In
mdx and DMD muscle, the absence of dystrophin leads to
secondary loss of DPC from the sarcolemma (8, 13, 17). Sim-
ilarly, in kidney, the loss of -dystrobrevin from the basolateral
region of epithelial cells of cortical renal tubules and collecting
tubules resulted in the loss of Dp71	C and all three syntrophin
isoforms. Likewise the absence of -dystrobrevin from liver
sinusoids led to the secondary loss of Dp71 isoforms and ap-
proximately two-thirds of 1-syntrophin molecules. Therefore
the membrane localization of these proteins in kidney and liver
requires the presence of -dystrobrevin. Consistent with this
idea, the levels of Dp71 isoforms and 1-syntrophin were re-
duced in microsome preparations of dtnb/ kidneys and liver
compared with those prepared from tissues of control litter-
mates. Since -dystrobrevin and dystroglycan colocalize in
both tissues (6) (Fig. 3A and 4A) and dystrobrevin has been
shown to bind to dystroglycan in vitro (5), -dystrobrevin may
serve to link interacting molecules to kidney and liver base-
ment membranes via an interaction with dystroglycan.
The function of -dystrobrevin-containing protein com-
plexes in kidney and liver is not known. Based on work carried
out on the dystrophin complexes in skeletal muscle, we know
that -dystrobrevin may be involved in intracellular signaling,
either directly or through its association with the syntrophins
(9). Therefore, we speculate that -dystrobrevin may act as a
scaffold for signaling molecules in a similar manner. Syntro-
FIG. 5. Western blot analysis of microsomes from control (/)
and -dystrobrevin-deficient (/) kidneys and liver. Thirty micro-
grams of microsomes was separated on SDS-PAGE gels (8% poly-
acrylamide). Blots were probed with the CT-FP (A), 1CT-FP (B),
URD40 (C), 2166 (D), 2401 (E), 2689 (F), and antiactin (G) antibod-
ies. The proteins detected by these antibodies are listed to the right of
the panels. The positions of protein standards are shown to the left in
kilodaltons. db, dystrobrevin; syn, syntrophin. TABLE 1. Protein/creatinine, calcium/creatinine, and
glucose/creatinine ratios of spot urine samples
Mouse group (n)
and parameter
Mean  SE amt of
protein (mg/mg)
Protein/creatinine ratio
Male
/ (7) ................................................................... 2.84  0.28
/ (9) ................................................................... 2.68  0.14
/ (10) ................................................................. 2.72  0.23
Female
/ (6) ................................................................... 1.37  0.11
/ (9) ................................................................... 1.45  0.11
/ (6) ................................................................... 1.46  0.10
Calcium/creatinine ratio
Male
/ (7) ................................................................... 0.161  0.036
/ (9) ................................................................... 0.122  0.021
/ (10) ................................................................. 0.179  0.048
Female
/ (6) ................................................................... 0.114  0.051
/ (9) ................................................................... 0.081  0.016
/ (6) ................................................................... 0.079  0.015
Glucose/creatinine ratio
Male
/ (7) ................................................................... 0.779  0.036
/ (9) ................................................................... 0.707  0.050
/ (10) ................................................................. 0.703  0.051
Female
/ (6) ................................................................... 0.642  0.030
/ (9) ................................................................... 0.700  0.032
/ (6) ................................................................... 0.734  0.029a
a P  0.05 for same-gender wild-type control versus dtnb/.
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phins recruit a variety of signaling molecules to the DPC via
binding to their PDZ domains. Recently, we showed that the
dystrobrevins, the dystrophin isoforms, and utrophin each con-
tain two tandem syntrophin binding motifs (16). Thus the loss
of -dystrobrevin and Dp71	C and the corresponding loss of
the syntrophins from the basal membranes of dtnb/ renal
tubules and liver suggest that potentially up to four syntrophin-
binding signaling molecules per DPC-like complex fail to be
recruited to the membrane. Despite its expression in many
nonmuscle tissues and its effect on its ligands in kidney and
liver, the normal appearance of the dtnb/ mice suggests that
-dystrobrevin is not important for the viability of the mouse.
An alternative explanation is that, under normal physiological
conditions, the effect of -dystrobrevin loss is masked, and the
true effect of this loss will only become evident when the renal
or hepatic system of these mice is challenged.
In conclusion, we have shown that -dystrobrevin is required
for the assembly of Dp71 and syntrophin molecules to the
basal membrane of kidney cells and liver sinusoids, but its
presence is not critical for the survival of -dystrobrevin-null
mice.
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